GOLDMAN SACHS GROUP INC - 31 Dec 2025 SCHEDULE 13G Report for JASPER THERAPEUTICS INC Voting Common Stock, par value $0.0001 per share (JSPR)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
JASPER THERAPEUTICS INC Voting Common Stock, par value $0.0001 per share
Symbol
JSPR
Shares outstanding
28,013,460 shares
Disclosed Ownership
1,764,848 shares
Ownership
6.3%
Form type
SCHEDULE 13G
Filing time
12 Feb 2026, 10:33:02 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GOLDMAN SACHS GROUP INC disclosed 6.3% ownership in JASPER THERAPEUTICS INC Voting Common Stock, par value $0.0001 per share (JSPR) on 31 Dec 2025."

Quick Takeaways

  • GOLDMAN SACHS GROUP INC filed SCHEDULE 13G for JASPER THERAPEUTICS INC Voting Common Stock, par value $0.0001 per share (JSPR).
  • Disclosed ownership: 6.3%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2026, 10:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 6.3% 1,764,848 0 1,764,848 Name: Abhilasha Bareja Attorney-in-fact
GOLDMAN SACHS & CO. LLC 6.3% 1,764,848 0 1,764,848 Name: Abhilasha Bareja Attorney-in-fact

Sponsored